# MK-3475 Immunotherapy in Endometrial Carcinoma

> **NCT02630823** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Endometrial Cancer
- Endometrial Carcinoma
- Neoplasms, Endometrial

## Interventions

- **DRUG:** MK-3475
- **PROCEDURE:** Surgical resection (standard of care)
- **DRUG:** Paclitaxel (standard of care)
- **DRUG:** Carboplatin (standard of care)
- **RADIATION:** Radiation (standard of care)
- **PROCEDURE:** Endometrial biopsy
- **PROCEDURE:** Peripheral blood draw

## Key facts

- **NCT ID:** NCT02630823
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-05
- **Primary completion:** 2019-01-01
- **Final completion:** 2020-10-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02630823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02630823, "MK-3475 Immunotherapy in Endometrial Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02630823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*